Ine Lentacker obtained her Master’ degree in pharmaceutical Sciences in 2004. In 2009, she obtained her PhD in pharmaceutical sciences under supervision of Prof. Stefaan De Smedt and Prof. Niek Sanders. Her PhD focused on the development of drug loaded microbubbles for ultrasound triggered gene-and drug delivery in the context of cancer therapy. During her FWO post-doctoral scholarship she further explored ultrasound triggered drug delivery as well as nanotechnology in the context of cancer immunotherapy. Since 2017, dr. Lentacker continues her research as a principal investigator in the Ghent Research Group on Nanomedicines where she is supervising several research projects at the interface of drug delivery and immunology.
Vaccine Delivery Group
Research projects of the Vaccine Delivery Group are situated at the interface of drug delivery and immunology.